Wasatch Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$174M Sell
907,159
-683,092
-43% -$111M 1.29% 18
2026
Q2
$217M Buy
1,590,251
+346,720
+28% +$42.6M 1.42% 19
2026
Q1
$147M Buy
+1,243,531
New +$174M 0.97% 41

Other funds holding RGEN

Wasatch Advisors's RGEN Position: Q3 2026 in Review

Wasatch Advisors reduced its Repligen (RGEN) stake by 43% in Q3 2026, selling an estimated $111M and leaving 907,159 shares worth $174M. The position accounts for 1.29% of the portfolio, ranked #18.

Wasatch Advisors first reported a position in RGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $217M in Q2 2026. 46 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Wasatch Advisors held 907,159 shares of Repligen worth $174M as of Q3 2026.
  • Wasatch Advisors sold 683,092 Repligen shares in Q3 2026, an estimated $111M.
  • Repligen made up 1.29% of Wasatch Advisors's portfolio in Q3 2026, its #18 holding.
  • Wasatch Advisors first reported a position in Repligen in Q1 2026 and has held it in 3 quarters since.
  • Wasatch Advisors's Repligen position peaked at $217M in Q2 2026.
  • 46 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Wasatch Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.